<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00333073</url>
  </required_header>
  <id_info>
    <org_study_id>CONSUI-EU02</org_study_id>
    <nct_id>NCT00333073</nct_id>
  </id_info>
  <brief_title>Effectiveness and Safety of Bulkamid® as Bulking Agent for the Treatment of Female Urinary Incontinence</brief_title>
  <official_title>Effectiveness and Safety of Bulkamid® as Bulking Agent for the Treatment of Female Urinary Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Contura</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Contura</source>
  <brief_summary>
    <textblock>
      To assess effectiveness of Bulkamid® injection in females suffering from stress or mixed
      (stress and urge) urinary incontinence after 12 months follow up period
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2006</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subjective responder rate after 12 months follow-up</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ICIQ</measure>
    <time_frame>Baseline, treatment, 1-, 6-, 12- and 24-months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>24 hour urine leakage</measure>
    <time_frame>Baseline, treatment, 1-, 6-, 12- and 24-months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>daily incidence of incontinence episodes</measure>
    <time_frame>Baseline, treatment, 1-, 6-, 12- and 24-months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Qol</measure>
    <time_frame>Baseline, treatment, 1-, 6-, 12- and 24-months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">125</enrollment>
  <condition>Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>Bulkamid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Submucosal injection of Bulkamid into urethra</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bulkamid</intervention_name>
    <description>initial injection with option for second (if required)</description>
    <arm_group_label>Bulkamid</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed consent

          -  Symptomatic stress or mixed urinary incontinence for at least 12 months

          -  Having at least 1 incontinence episode per day over three days

        Exclusion Criteria:

          -  Regular or intermittent users of an urethral catheter

          -  Pregnant women

          -  Suffer from severe allergies or anaphylaxis

          -  Suffer from autoimmune diseases or any unstable or sever cardio-vascular disease

          -  History of any cancer within the last 5 years

          -  Previous surgery for the treatment of urinary incontinence, including bulking
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gunnar Lose, Prof., MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>KAS Glostrup</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Skejby Sygehus</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>KAS Glostrup</name>
      <address>
        <city>Glostrup</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DRK Gemeinnützige Krankenhaus Gmbh</name>
      <address>
        <city>Chemnitz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Karolinska Institutet</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Södersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Worthing Hospital</name>
      <address>
        <city>Worthing</city>
        <state>West Sussex</state>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Birmingham Women´s Hospital</name>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Hartlepool</name>
      <address>
        <city>Hartlepool</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. George´s Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Finland</country>
    <country>Germany</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.bulkamid.com/</url>
    <description>Bulkamid Website</description>
  </link>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 1, 2006</study_first_submitted>
  <study_first_submitted_qc>June 1, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 2, 2006</study_first_posted>
  <last_update_submitted>February 14, 2014</last_update_submitted>
  <last_update_submitted_qc>February 14, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>urinary incontinence</keyword>
  <keyword>Bulkamid</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

